Who is sponsoring NCT05560594?

NCT05560594 is sponsored by Coloplast A/S.

What drugs are being tested in NCT05560594?

Interventions in NCT05560594: Coloplast SpeediCath CH12 standard male intermittent catheter.

What condition does NCT05560594 study?

NCT05560594 studies Urinary Function.

Is NCT05560594 still recruiting?

NCT05560594 is currently completed. Last updated 18 October 2022.

Last reviewed 2022-10-18 · How we verify

NCT05560594

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigate Bladder and Prostate During Emptying With Intermittent Catheter

Completed NA Last updated 18 October 2022

What this trial tests

NA trial testing Coloplast SpeediCath CH12 standard male intermittent catheter in Urinary Function in 12 participants. Completed in 25 August 2022.

Timeline

27 February 2022

Primary endpoint
25 August 2022

25 August 2022

Quick facts

Lead sponsor	Coloplast A/S
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	12
Start date	27 February 2022
Primary completion	25 August 2022
Estimated completion	25 August 2022
Sites	1 location across Denmark

Drugs / interventions tested

Coloplast SpeediCath CH12 standard male intermittent catheter

Conditions studied

Urinary Function — all drugs for Urinary Function →

Sponsor

Coloplast A/S — full company profile →

Who can join

18 and older, male only, with Urinary Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Explorative study investigating the urinary bladder and prostate during intermittent catheterization in healthy male adults by use of MR-scanning.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Coloplast A/S trials

Trials by the same sponsor.

NCT07475468 — CP382 - Intermittent Catheter (IC) PRO Panel Plan · not yet recruiting
NCT07384559 — Exploratory Study Investigating the Urinary Bladder During Intermittent Catheterization in Healthy and Spinal Cord Injur · NA · not yet recruiting
NCT07376421 — Clinical Investigation Exploring a Newly Developed Ostomy Baseplate · NA · recruiting
NCT07126327 — Peristeen Light Explorative Clinical Investigation · NA · recruiting
NCT07316530 — Clinical Investigation Exploring a Newly Developed Ostomy Baseplate. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05560594 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Coloplast A/S
Last refreshed: 18 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05560594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing